Fresenius SE & Co. KGaA (FRA:FRE – Get Rating) has been given a €52.50 ($56.45) price target by equities researchers at Barclays in a research report issued on Tuesday, Borsen Zeitung reports. Barclays‘s price objective indicates a potential upside of 63.14% from the company’s current price. FRE has been the subject of several other reports. […]
Fresenius SE & Co. KGaA (FRA:FRE – Get Rating) received a €33.30 ($35.43) price target from equities research analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Wednesday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s price target points to a potential upside of 5.21% from the company’s current […]
Zacks Investment Research lowered shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) from a hold rating to a sell rating in a research report report published on Wednesday, Zacks.com reports. According to Zacks, “Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient […]
By Milla Nissi (Reuters) - German healthcare group Fresenius's first-quarter profit exceeded market expectations on Wednesday, driven by growth in its.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.